News tagged with therapeutic effect
Researchers shrink tumors, minimize side effects using tumor-homing peptide to deliver treatment
The trouble with most anti-cancer therapies is that they are lethal to most cells in the body, not just cancer cells. As a result, patients experience side effects like nausea, increased susceptibility to ...
Cancer
Nov 21, 2011 |
5 / 5 (5) |
1
|
Study finds mechanism that turns white fat into energy-burning brown fat
Columbia University Medical Center (CUMC) researchers have identified a mechanism that can give energy-storing white fat some of the beneficial characteristics of energy-burning brown fat. The findings, based on studies of ...
Medical research
Aug 02, 2012 |
4.6 / 5 (5) |
0
|
Placebo response, pain experience occur at nonconscious level: study
With the discovery that the unconscious mind plays a key role in the placebo effect, researchers have identified a novel mechanism that helps explain the power of placebos and nocebos.
Medical research
Sep 10, 2012 |
5 / 5 (4) |
1
Molecular corkscrew
Scientists from the universities of Zurich and Duisburg-Essen have discovered a specific function of the protein p97/VCP. They demonstrate that the protein repairs DNA breaks like a corkscrew, a repair mechanism that could ...
Medical research
Nov 08, 2011 |
5 / 5 (3) |
0
Novel intercellular transportation system may have potential for delivering RNAi and other gene-based therapeutics
(Medical Xpress)—Important new research from UMass Medical School demonstrates how exosomes shuttle proteins from neurons to muscle cells where they take part in critical signaling mechanisms, an exciting ...
Neuroscience
Mar 27, 2013 |
5 / 5 (3) |
0
|
New study points to potential new therapies for cancer and other diseases
Researchers at The Scripps Research Institute (TRSI) are fueling the future of cancer treatment by improving a powerful tool in disease defense: the body's immune system. By revealing a novel but widespread cell signaling ...
Medical research
Nov 27, 2012 |
4.7 / 5 (3) |
0
Scientists establish a new class of anti-diabetic compound
In a joint study, scientists from The Scripps Research Institute and Harvard University's Dana-Farber Cancer Institute have established a new class of anti-diabetic compound that targets a unique molecular switch.
Medical research
Sep 04, 2011 |
3.7 / 5 (3) |
0
|
Reducing the side effects of treatment for prostate cancer
New research published in BioMed Central's open access journal BMC Medicine reassessing clinical data from trials, which investigate ways of treating side effects of therapy for prostate cancer, finds that tamoxifen, an ant ...
Cancer
Aug 27, 2012 |
4.5 / 5 (2) |
0
Federal government says marijuana has no accepted medical use
Marijuana has been approved by many states and the nation's capital to treat a range of illnesses, but the federal government has ruled that it has no accepted medical use and should remain classified as a dangerous drug ...
Health
Jul 13, 2011 |
2.3 / 5 (3) |
0
Anti-cancer drug fights immune reaction in some infants with Pompe disease
Adding a third anti-cancer agent to a current drug cocktail appears to have contributed to dramatic improvement in three infants with the most severe form of Pompe disease—a rare, often-fatal genetic disorder ...
Genetics
Oct 11, 2012 |
3.5 / 5 (2) |
0
New pretargeted radioimmunotherapy for colorectal cancer
Investigators at SNM's 58th Annual Meeting are presenting results from a phase 1 clinical trial for a cancer therapy that has the potential to kill colorectal tumors with less destruction of healthy tissue. Further research ...
Cancer
Jun 06, 2011 |
5 / 5 (1) |
0
Researchers map pathway of infection for a common, potentially life-threatening respiratory virus
Researchers at the University of Toronto, The Hospital for Sick Children (SickKids), St. Paul's Hospital and the University of British Columbia have identified a new treatment target for a virus that causes severe lung infections ...
Medical research
Aug 15, 2011 |
5 / 5 (1) |
0
|
Two targeted therapies act against Ewing's sarcoma tumors
A pair of targeted therapies shrank tumors in some patients with treatment-resistant Ewing's sarcoma or desmoplastic small-round-cell tumors, according to research led by investigators from The University of Texas MD Anderson ...
Cancer
Apr 01, 2012 |
5 / 5 (1) |
0
|
Cell contents may be key to controlling toxicity of Huntington's disease protein
New research into the cell-damaging effects of Huntington's disease suggests a potentially new approach for identifying possible therapeutic targets for treating the nerve-destroying disorder.
Genetics
Jun 06, 2012 |
5 / 5 (1) |
0
|
Double duty: Immune system regulator found to protect brain from effects of stroke
A small molecule known to regulate white blood cells has a surprising second role in protecting brain cells from the deleterious effects of stroke, Johns Hopkins researchers report. The molecule, microRNA-223, affects how ...
Immunology
Nov 28, 2012 |
5 / 5 (1) |
0
|
